Cargando…
Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces
The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for the Advancement of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880770/ https://www.ncbi.nlm.nih.gov/pubmed/35213224 http://dx.doi.org/10.1126/sciadv.abm3608 |
_version_ | 1784659303274119168 |
---|---|
author | Rosella, Laura C. Agrawal, Ajay Gans, Joshua Goldfarb, Avi Sennik, Sonia Stein, Janice |
author_facet | Rosella, Laura C. Agrawal, Ajay Gans, Joshua Goldfarb, Avi Sennik, Sonia Stein, Janice |
author_sort | Rosella, Laura C. |
collection | PubMed |
description | The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen test (RAT) program. The screening program identified 473 asymptomatic individuals who tested positive on the RAT and confirmed positive by a nasopharyngeal polymerase chain reaction (PCR) diagnostic test. One in 4300 RATs was presumptive positive but later tested PCR negative, and thus, false positives did not meaningfully disrupt workplace operations. Most employers rated the program highly and felt strongly that the program contributed to workplace and community safety. The findings describe a sustained and scalable implementation plan for establishing a frequent workplace testing program. High-frequency testing programs offer the potential to break chains of transmission and act as an extra layer of protection in a comprehensive public health response. |
format | Online Article Text |
id | pubmed-8880770 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Association for the Advancement of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88807702022-03-10 Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces Rosella, Laura C. Agrawal, Ajay Gans, Joshua Goldfarb, Avi Sennik, Sonia Stein, Janice Sci Adv Social and Interdisciplinary Sciences The transmission of coronavirus disease 2019 (COVID-19) in workplaces has been a persistent issue throughout the pandemic. In response, a not-for-profit initiative emerged to mitigate COVID-19 workplace transmission in Canada. We report the process for establishing a workplace frequent rapid antigen test (RAT) program. The screening program identified 473 asymptomatic individuals who tested positive on the RAT and confirmed positive by a nasopharyngeal polymerase chain reaction (PCR) diagnostic test. One in 4300 RATs was presumptive positive but later tested PCR negative, and thus, false positives did not meaningfully disrupt workplace operations. Most employers rated the program highly and felt strongly that the program contributed to workplace and community safety. The findings describe a sustained and scalable implementation plan for establishing a frequent workplace testing program. High-frequency testing programs offer the potential to break chains of transmission and act as an extra layer of protection in a comprehensive public health response. American Association for the Advancement of Science 2022-02-25 /pmc/articles/PMC8880770/ /pubmed/35213224 http://dx.doi.org/10.1126/sciadv.abm3608 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited. |
spellingShingle | Social and Interdisciplinary Sciences Rosella, Laura C. Agrawal, Ajay Gans, Joshua Goldfarb, Avi Sennik, Sonia Stein, Janice Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title | Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title_full | Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title_fullStr | Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title_full_unstemmed | Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title_short | Large-scale implementation of rapid antigen testing system for COVID-19 in workplaces |
title_sort | large-scale implementation of rapid antigen testing system for covid-19 in workplaces |
topic | Social and Interdisciplinary Sciences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880770/ https://www.ncbi.nlm.nih.gov/pubmed/35213224 http://dx.doi.org/10.1126/sciadv.abm3608 |
work_keys_str_mv | AT rosellalaurac largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces AT agrawalajay largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces AT gansjoshua largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces AT goldfarbavi largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces AT senniksonia largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces AT steinjanice largescaleimplementationofrapidantigentestingsystemforcovid19inworkplaces |